Non-Small Cell Lung Cancer (NSCLC)

Posted On 2020-09-02 11:42:10


The series “Non-Small Cell Lung Cancer (NSCLC)” was edited by Dr. Alfredo Addeo, Oncology Department, University Hospital Geneva, Geneva, Switzerland and Dr. Giuseppe Banna, Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy.

Original Article
Digging deep or spreading wide?—a comparison of polymerase chain reaction and sequencing approaches in the analysis of circulating tumor DNA
Thierry Nouspikel

Review Article
Role and room for biomarkers in non-small cell lung cancer
Glen J. Weiss

The role of immunotherapy in mesothelioma
Gina Colarusso, Julie Terzic, Vérane Achard, Alex Friedlaender

Pathology in non-small cell lung cancer: evolving scenario
Pasquale Pisapia, Francesco Pepe, Antonino Iaccarino, Giancarlo Troncone, Umberto Malapelle

Lung cancer screening: where do we stand?
Fabrizio Minervini, Marco Scarci

How to recognize and manage hyper-progression and pseudo-progression during immune checkpoint blockade in non-small cell lung cancer
Francesco Facchinetti, Giuseppe Lo Russo, Marcello Tiseo, Marina Chiara Garassino, Roberto Ferrara

Non-small cell lung cancer targetable mutations: present and future
Peter Vu, Sandip Pravin Patel

NTRK and NRG1 gene fusions in advanced non-small cell lung cancer (NSCLC)
Alessandro Russo, Ana Rita Lopes, Katherine Scilla, Ranee Mehra, Vincenzo Adamo, Julio Oliveira, Stephen V. Liu, Christian Rolfo


Disclosure:
The series “Non-Small Cell Lung Cancer (NSCLC)” was commissioned by the editorial office, Precision Cancer Medicine without any sponsorship or funding. Alfredo Addeo and Giuseppe Banna served as the unpaid Guest Editors for the series.